Consider a world where medical technology has conquered diseases such as cancer and aging is no longer an unavoidable fate. While this concept may seem distant, there is a company, Alcor Life Extension Foundation, that is committed to narrowing the gap between today and this extraordinary future.
Alcor, headquartered in the United States, proudly claims the title of the world’s leading cryonics company. Their audacious vision involves preserving human bodies at ultra-low temperatures, with the hope of eventual revival. Picture this: you go to sleep today, only to wake up decades or even centuries later, when medical advancements have conquered aging and death.
The science behind Alcor’s unique business is called cryonics. Through a process known as vitrification, they replace the body’s blood with a cryoprotectant solution, preventing ice crystal formation that could harm cells and tissues. Once vitrification is complete, the body is gradually cooled to a chilling -196 degrees Celsius and stored in a vacuum-insulated metal container filled with liquid nitrogen.
But here’s the big question: Can Alcor truly revive these frozen bodies? The Department of Anatomy at AIIMS Rajkot acknowledges the uncertainty. While current medical science lacks the means to reverse cryopreservation or repair cellular damage, Alcor and its supporters remain optimistic. They place their bets on future breakthroughs in nanotechnology and regenerative medicine.
Why Freeze Without Guarantees?
Despite the uncertainty, people choose cryonics for the tantalizing promise of extended life and witnessing future marvels. Alcor offers hope, even if it comes without promises or timelines.
Predictably, the allure of immortality attracts the wealthy. Estate attorneys are creating trusts aimed at preserving wealth for cryonically preserved individuals until they can potentially be revived many years later. These “revival trusts” are based on certain assumptions and are becoming more popular among believers and industry experts.
When signing up for cryopreservation, a significant portion of funding goes into the Alcor Patient Care Trust. Whole-body preservation costs $115,000, while neuro preservation (head-only) is priced at $25,000. Membership options include monthly dues ranging from $17 to $100, with an additional $60 per year for each child.
Cryonics sparks ethical and scientific debates. Critics argue that false hope may be the outcome without a clear path to revival. Questions abound: How can frozen tissues avoid deterioration over time? Can the freezing process be reversed harmlessly? And how do we restore the identity of revived individuals?
The Cryonic Quest
Mark House, an estate lawyer associated with the Alcor Life Extension Foundation, one of the world’s largest cryonics facilities, notes a change in people’s attitudes. Cryopreservation, once considered a fringe idea, is now seen as intriguing and somewhat eccentric.
About 5,500 individuals are planning for cryogenic preservation, and House has closely worked with around 100 of them. The questions raised by these trusts are more about philosophy than legality:
1. Can Wealth Live Indefinitely? Can wealth outlast time, much like life itself?
2. Are You Considered Deceased If Preserved? Are cryonically-preserved bodies considered alive or dead?
3. Brain vs. Body: If revived, is a preserved brain enough?
4. Identity After Revival: Will a revived person remain the same individual?
Steve LeBel, a retired hospital executive, wants to be cryonically preserved like others before him. At 76, he’s busy writing young adult fantasy novels and cherishing life. His idea is to create a “revival trust,” which is a variation of a dynasty trust. Both trusts evade the 40% federal estate tax, but in the revival trust, the revived person is the sole beneficiary. LeBel plans to set aside $100,000 for his future revival, leaving the rest for his family and foundation.
But these trusts are pushing boundaries. Perpetual trusts, once considered unacceptable, now challenge time itself. Some states allow trusts to last for centuries – Arizona, 500 years; Florida, 1,000 years. However, planning for millennia is still a leap of faith. What happens if the rules change? What if revival turns out to be impossible? Flexibility and succession planning become crucial.
Who Determines Immortality?
As science hints at immortality, the number of cryonics enthusiasts is growing. Tech moguls like Jeff Bezos and Larry Page are investing millions in defying death. Recently, Cradle Healthcare Co. pledged $48 million to develop rewarming technology, strengthening the industry’s credibility.
Steve LeBel sums it up: “The aging process is a disease. Cryonics bridges the gap until technology catches up.” In this frozen dance between life and eternity, the question remains: Who holds the key to revival?
As the clock ticks on cryonics, the wealthy and curious are preparing for their last great experiment – a wager against time itself.
You might also be interested in – First in the world, gene therapy for blood diseases approved in the UK
